Menu
Recruiting NCT07204990

BELUGA: Better to Exchange ETT for LMA Before Extubation in Children Under General Anaesthesia

No phase Interventional Endotracheal Extubation Airway Anesthesia Paediatric

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Direct removal of endotracheal tube, Laryngeal mask airway inserted following deep extubation.
Who it may be relevant to
Registry conditions: Endotracheal Extubation, Airway Anesthesia, Paediatric. Basic parameters: 0 years — 16 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States, Australia, Brazil, Italy, Sweden +1
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

During surgery, anaesthetists can use an endotracheal tube (ETT) to facilitate ventilation. At emergence from general anaesthesia, there are two techniques for removal of the ETT: (1) the ETT is removed when the child is waking up in (awake removal); or (2) the ETT is removed while still under anaesthesia(deep removal). Currently there is no evidence to suggest either technique is safer - deep removal of the ETT may decrease the risk of overall airway complications, including cough and desaturations. However, it may be associated with increased airway obstruction compared with awake extubation in paediatric patients. In our institution, a further technique has become increasingly common practice: removing ETT deep to avoid coughing and desaturation, then inserting a laryngeal mask airway (LMA) which can be removed once the patient is awake in the postoperative care unit (PACU), avoiding the risk of airway obstruction coupled with deep airway removal. The aim of the study is to assess whether deep removal of an ETT and exchange to an LMA, is superior to awake ETT removal with regards to the occurrence of postoperative respiratory adverse events. In this study, patients will be randomised to awake removal of ETT or deep removal of an ETT and exchange to an LMA. Data will be collected regarding the rate of respiratory adverse events in either group, as well as the incidence of post-operative pain, delirium and nausea and vomiting.

Detailed description

Anaesthesia induction and maintenance will be performed as deemed appropriate by the attending anaesthetist. The choice and dose of analgesia will be at the discretion of the individual anaesthetist adjusted to the individual patient's needs. All clinical care will be in accordance with institutional standards.

All children undergoing surgery under general anaesthesia involving insertion of an endotracheal tube who arrive in the PCH post-anaesthetic care unit (PACU) between 0800 and 1800 on weekdays during the data collection periods will be included in this study under a waiver of consent. Surgical lists in our institution operate on four-week cycles (weeks A, B, C and D), with some surgical specialities scheduled for one list a fortnight or one list every four weeks and others having multiple lists per week. In order to ensure that both intervention groups have equal representation of each of the weeks A, B C and D, data collection will take place in 8-week blocks until such a time as the sample size has been reached.

Group ETT awake: ETT removal once the patient is fully awake (at least 3 of the following criteria: spontaneous tidal volume \>5ml/kg, conjugate gaze, facial grimace, eye-opening, purposeful movement Group LMA exchange: ETT removal deep; @ at least 1 Mac or an equivalent depth of anaesthesia (if available BIS \<60, Sedline \<50), an additional bolus of propofol (1mg/kg) maybe given if deemed appropriate/ required prior to the ETT removal as per normal clinical practice. Following gentle suctioning around the ETT at the end of the case, the ETT is removed under deep anaesthesia and a LMA is inserted in its place.

There is no individual randomisation or blinding in this study. Extubation procedure (either ETT removed awake or ETT removed deep and exchanged for LMA) will each be used for 4 out of 8 weeks during the data collection period. The intervention assigned for the first 4-week cycle of the data collection period will be decided by the toss of a coin. Thereafter, intervention 1 (either ETT awake or LMA exchange) will be in place for weeks 4 weeks, with the alternate intervention in place for the subsequent 4 weeks. Given the nature of the intervention it is not possible to have blinding for this study. The statistical analysis will be performed by individuals blinded to the randomisation. This will be repeated until the required sample size has been reached

Demographic information routinely collected as part of normal clinical care will be recorded on a patient data sheet, including their date of birth, natal sex, height, weight, ethnicity and age on the day of surgery. Details about their condition on the day of surgery will be collected, including their American Society of Anaesthesiologists physical status (ASA) I-IV, any upper respiratory tract infections in the last two weeks, current or previous respiratory risk factors, and any signs of obstructive sleep apnoea, details of know abnormal pulse oximetry, risk factors for postoperative nausea and vomiting and any history of prematurity. Details of their anaesthetic management and their time spend in the post-anaesthetic care unit (PACU) will also be recorded, as well as any incidence of respiratory adverse events at any time from induction of anaesthesia until discharge from PACU. Incidence of sore throat or hoarse voice will be collected on the day of surgery 2-4 hours post PACU discharge.

Interventions

  • Procedure Direct removal of endotracheal tube
    Patient will have direct removal of ETT and transferred to PACU breathing independently or with a face mask.
  • Procedure Laryngeal mask airway inserted following deep extubation
    Patient will have LMA inserted following deep extubation of endotracheal tube.

Primary outcome measures

  • Compare the overall rate of perioperative respiratory adverse events in children following either (1) directly at the end of surgery or (2) exchange of ETT for LMA followed by awake removal of LMA [Time frame: Assessed by the anaesthetist along the course of the patient's perioperative pathway from extubation until their discharge from the post-anaesthetic care unit (PACU)]
Secondary outcome measures (9)
  • Compare the rate of specific perioperative respiratory adverse events in children following either (1) direct removal of ETT or (2) exchange of ETT for LMA followed by awake removal of LMA [Time frame: Assessed by the anaesthetist along the course of the patient's perioperative pathway from extubation until their discharge from the post-anaesthetic care unit (PACU)]
  • Compare the rate of required post-operative airway interventions in children following either (1) direct removal of ETT or (2) exchange of ETT for LMA followed by awake removal of LMA [Time frame: Any airway interventions given along the course of the patient's perioperative pathway from extubation until their discharge from the post-anaesthetic care unit (PACU) will be recorded]
  • Comparison of postoperative delirium scores in PACU (post anaesthetic care unit)between the two groups using the Paediatric Anaesthesia Emergence Delirium (PAED) scale 10 minutes after awake (UMSS <2) [Time frame: A single measurement of using the PAED score will be taken 10 minutes after the patient is assessed to first be at a UMSS of 2 as per the PACU nurse.]
  • Comparison of pain scores 5 and 20 min post airway removal (ETT in the direct removal ETT group and LMA removal in the exchange group) between the two groups [Time frame: Assessments of pain will be taken at 5 and 20 minutes after the patient is assessed to first be at a UMSS of 2 as per the PACU nurse.]
  • Comparison of the number of additional opioid analgesia use in PACU between the two groups [Time frame: All opioid analgesia usage from PACU admission until discharge will be recorded.]
  • Comparison of time between the end of surgery and arrival in PACU between the two groups and time to UMSS <2 (awake) [Time frame: Time at which patient arrives in PACU and time at which their UMSS score is ≤2 will be measured by the PACU nurse during their post-operative PACU admission. Measured in minutes/hours on day of surgery for each patient.]
  • Comparison of PACU time between the two groups [Time frame: PACU time is defined as the time from arrival in PACU until ready for discharge from PACU.]
  • To compare rates of vomiting and self-reported nausea in PACU between the two groups [Time frame: Assessed from the time at which the patient is admitted to PACU until the time that they are discharged.]
  • To compare the incidence of sore throat and hoarse voice between the two groups [Time frame: Collected on the day of surgery, 2-4 hours post discharge from PACU.]

Eligibility criteria

Participant Inclusion Criteria

  • Children 0-16 years,
  • 5kg and above,
  • presenting for elective, semi-elective or emergency surgery under general anaesthesia
  • With airway management planned with an endotracheal tube.

Exclusion criteria

  • Children with severe cardiopulmonary disease or syndrome
  • Children < 5kg
  • Children with a contraindication to deep removal of ETT deep or exchange of ETT to LMA at the end of the case (e.g. high risk of aspiration)
  • Children with a known or anticipated difficult airway
  • Children remaining intubated post-procedure
  • Children undergoing major airway surgery or bronchoscopies

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Prevention

Study locations

United States · 2 centers
  • Atrium Health Wake Forest Baptist — Winston-Salem
  • The Children's Hospital of Philadelphia — Philadelphia
Australia · 2 centers
  • Perth Children's Hospital — Nedlands
  • The Kids Research Institute Australia — Nedlands
Brazil · 1 center
  • University of São Paulo — São Paulo
Italy · 1 center
  • Istituto Giannina Gaslini — Genova
Sweden · 1 center
  • Uppsala University Hospital — Uppsala
Switzerland · 1 center
  • Bern University Hospital — Bern

Identifiers

NCT: NCT07204990 · RGS0000007646

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗